The following impurities are available with SUMA Laboratories Pvt Limited. Click here to Download our impurities in pdf format...
Product list 201 - 250:
| S.No | Compound Name | CAS | Remarks |
|---|---|---|---|
| 201 | 4-((7-Chloroquinolin-4-yl)amino)-N-ethyl-N-(2-hydroxyethyl)pentan-1-amine oxide | 1449223-88-4 | Hydroxy chloroquine Imp A |
| 202 | sodium 2-((4-((7-Chloroquinolin-4-yl)amino)pentyl)(ethyl)amino)ethyl sulfate | 103152-84-7( Free Acid) | Hydroxy chloroquine Imp B |
| 203 | 2-((4-((7-Chloroquinolin-4-yl)amino)pentyl)amino)ethan-1-ol | 4298-15-1 | Hydroxy chloroquine Imp C |
| 204 | N4-(7-Chloroquinolin-4-yl)-N1-ethylpentane-1,4-diamine | 1476-52-4 | Hydroxy chloroquine Imp D |
| 205 | Hydroxy chloroquine Imp E | 10500-64-8 | |
| 206 | 4-((7-chloroquinolin-4-yl)amino)pentan-1-ol | 6281-58-9 | Hydroxy chloroquine Imp F |
| 207 | 4,7-Dichloroquinoline | 86-98-6 | Hydroxy chloroquine Imp G |
| 208 | 2-[[4-[(7-Chloro-4-quinolinyl) amino] pentyl] ethylamino] ethanol 1-Acetate | 47493-14-1 | Hydroxy chloroquine O-Acetyl impurity |
| 209 | 4-(4-Amino-3-fluorophenoxy)-N-methylpyridine-2-carboxamide | 757251-39-1 | Regorafenib impurity -A |
| 210 | 4-(4-Acetamido-3-fluorophenoxy)-N-methylpyridine-2-carboxamide | 2141961-84-2 | Regorafenib impurity -B |
| 211 | 4-[3-Fluoro-4-[[2-(methylcarbamoyl)pyridin-4-yl]amino]phenoxy]-N-methylpyridine-2-carboxamide | 1855006-12-0 | Regorafenib impurity -C |
| 212 | 4,4'-(((Carbonylbis(azanediyl))bis(3-fluoro-4,1-phenylene))bis(oxy))bis(N-methylpicolinamide) | NA | Regorafenib impurity -D |
| 213 | 4-(4-(3-(4-Chloro-3-(trifluoromethyl) phenyl)ureido)-3-(4-(3-(4-chloro-3-(trifluoromethyl)phenyl)ureido)-3-fluorophenoxy)phenoxy)-N-methylpicolinamide. | 2098799-13-2 | Regorafenib impurity E( In progress) |
| 214 | 5-Imino-4-methyl-4, 5-dihydro-1, 3, 4-thiadiazole-2-sulfonamide | 86029-46-1 | IMTS IMPURITY( Methozolomide impurity) |
| 215 | 1-Hydroxy-3-(2-methoxyphenoxy)propan-2-yl carbamate | 10488-39-8 | Methocarbamol B-Isomer |
| 216 | 4-((2-Methoxyphenoxy) methyl)-1,3-dioxolan-2-one | 2049-21-0 | rac Guaifenesin Cyclic Carbonate |
| 217 | (2, 6-Dichlorophenyl) carbonimidic dichloride | 21709-18-2 | Clonidine Impurity |
| 218 | 4-Chloro-N-(4-methoxyphenyl)benzamide | 4018-82-0 | Indomethacin EP Impurity C |
| 219 | 4-Chloro-N'-(4-chlorobenzoyl)-N-(4-methoxyphenyl)benzohydrazide | 402849-27-8 | Indomethacin Dibenzylate impurity |
| 220 | 2,6-Dichloroformanilide | 10113-35-6 | Impurity Standard |
| 221 | N-Eathyl-2-phenyl-N-(pyridin-4-ylmethyl) acrylamide | 57322-50-6 | Tropicamide EP Impurity B |
| 222 | 2-(2-(Dimethylamino)ethoxy)ethan-1-ol | 1704-62-7 | Butamirate Citrate Impurity A |
| 223 | 2-Phenylbutanoic acid | 90-27-7 | Butamirate Citrate Impurity B |
| 224 | 2-(2-(Diethylamino)ethoxy)ethyl 2-phenylacetate | 47092-75-1 | Butamirate Citrate Impurity C |
| 225 | N,N-Diethyl-2-phenylbutanamide | 92321-53-4 | Butamirate Citrate Impurity D |
| 226 | Phenyl Acetic acid | 103-82-2 | Butamirate Citrate Impurity E |
| 227 | Methyl 2-phenylbutanoate | 2294-71-5 | Butamirate methyl Butanoate |
| 228 | 2-(2-(Diethylamino)ethoxy)ethyl 2-phenylbutanoate | 18109-80-3 | BUTAMIRATE WS |
| 229 | 2-Amino-4-(methylthio)aniline | 67469-02-7 | Alb-F- Amine |
| 230 | 2-(3-((1-Ethoxy-1-oxo-4-phenylbutan-2-yl)amino)-2-oxo-2,3,4,5-tetrahydro-1H-benzo[b]azepin-1-yl)acetic acid | 98626-50-7 | Benazepril impurity B |
| 231 | L- Glutamic Acid α-Ethyl Ester | 52454-78-1 | Impurity Standard |
| 232 | 5-Nitroisophthalic acid | 618-88-2 | Glycopyrrolate Related compound-A |
| 233 | 1-Methylpyrrolidin-3-yl 2-cyclopentyl-2-hydroxy-2-phenylacetate | 13118-11-1 | Glycopyrrolate Related compound-B |
| 234 | 2-cyclopentyl-2-hydroxy-2-phenylacetic acid | 427-49-6 | Glycopyrrolate Related compound-C |
| 235 | Methyl 2-cyclopentyl-2-hydroxy-2-phenylacetate | 19833-96-6 | Glycopyrrolate related compound L |
| 236 | 3-[[2-(4-Chlorophenyl)-2-cyclopentyl-2-hydroxyacetyl]oxy]-1,1-dimethylpyrrolidinium Bromide | 1404453-68-4 | Chloro Glycopyrrolate(Glycopyrrolate related compound I)In progress |
| 237 | 1-Methylpyrrolidin-3-ol | 13220-33-2 | Glycopyrrolate in house impurity |
| 238 | 3-(2-(cyclopent-1-en-1-yl)-2-hydroxy-2-phenylacetoxy)-1,1-dimethylpyrrolidin-1-ium bromide | Not Available | Dehydro Glycopyrrole impurity |
| 239 | ((RS)-3-[(RS)-2-Cyclopentyl-2-hydroxy-2-phenylacetoxy]-1,1-dimethylpyrrolidinium bromide) | 475468-09-8 (R,R)201667-20-1 (S,S) | Glycopyrrolate Erythro isomer |
| 240 | 1,1-Dimethyl-3-hydroxypyrrolidinium Bromide | 51052-74-5 | Glycopyrrolate Impurity 1 |
| 241 | 2-Amino 4-methyl thio aniline | 67469-02-7 | Albendazole impurity-F-amine |
| 242 | 5-[4'-(Azidomethyl)[1,1'-biphenyl]-2-yl]-2H-tetrazole | 152708-24-2 | Valsartan ABT impurity |
| 243 | 7-Chloro-4-(4-hydroxyphenylamino) quinolone | 81099-86-7 | Amodiaquine Impurity C |
| 244 | 4-Chloro-N-(4,5-dihydro-1H-imidazol-2-yl)-6-methoxy-2-methyl-5-pyrimidinamine | 75438-57-2 | Moxonidine WS |
| 245 | 4,6-Dichloro-N-(imidazolidin-2-ylidene)-2-methylpyrimidin-5-amine | 352457-35-3 | Moxonidine EP Impurity A |
| 246 | N-(4,5-Dihydro-1H-imidazol-2-yl)-4,6-dimethoxy-2-methyl-5-pyrimidinamine | 75439-01-9 | Moxonidine EP Impurity B |
| 247 | N-[[(5S)-2-Oxo-3-[4-(3-oxomorpholin-4-yl)phenyl]-1,3-oxazolidin-5-yl]methyl]acetamide | 1429334-00-8 | Rivaroxaban EP Impurity B |
| 248 | (S)-4-(4-(5-(Aminomethyl)-2-oxooxazolidin-3-yl)phenyl)morpholin-3-one | 446292-10-0 | Rivaroxaban Amino methyl Base Impurity |
| 249 | 4-[4-[(5S)-5-(Aminomethyl)-2-oxo-3-oxazolidinyl]phenyl]-3-morpholinone Hydrochloride | 898543-06-1 | Rivaroxaban Amino methyl HCl Impurity |
| 250 | 5-Chloro-N-methylthiophene-2-carboxamide | 97799-98-9 | Rivaroxaban CMTCA Impurity |
Suma Laboratories ® All rights reserved.